
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | $18M | |
Other Inc / (Exp) | -- | -- | -- | -- | $1.8M | |
Operating Expenses | -- | -- | -- | -- | $18M | |
Operating Income | -- | -- | -- | -- | -$18M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -$23.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -$23.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -$23.8M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -$0.55 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -$0.55 | |
Weighted Average Basic Share | -- | -- | -- | -- | $42.8M | |
Weighted Average Diluted Share | -- | -- | -- | -- | $42.8M | |
EBITDA | -- | -- | -- | -- | -$16.1M | |
EBIT | -- | -- | -- | -- | -$16.1M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -$18M | |
Operating Income (Adjusted) | -- | -- | -- | -- | -$16.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | $1.2M | $5.7M | |
Other Inc / (Exp) | -- | -- | -- | -$162.6K | $2.2M | |
Operating Expenses | -- | -- | -- | $1.2M | $5.7M | |
Operating Income | -- | -- | -- | -$1.2M | -$5.7M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -$1.4M | -$3.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -$1.4M | -$3.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -$1.4M | -$3.8M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -$0.03 | -$0.07 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -$0.03 | -$0.07 | |
Weighted Average Basic Share | -- | -- | -- | $46.7M | $53M | |
Weighted Average Diluted Share | -- | -- | -- | $46.7M | $53M | |
EBITDA | -- | -- | -- | -$1.4M | -$3.7M | |
EBIT | -- | -- | -- | -$1.4M | -$3.7M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -$1.2M | -$5.7M | |
Operating Income (Adjusted) | -- | -- | -- | -$1.4M | -$3.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | $22.7M | |
Other Inc / (Exp) | -- | -- | -- | $3.7M | $3.8M | |
Operating Expenses | -- | -- | -- | -- | $22.7M | |
Operating Income | -- | -- | -- | -- | -$22.7M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -$26.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -$26.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -$26.6M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -$0.57 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -$0.57 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -- | -- | -$17.2M | |
EBIT | -- | -- | -- | -- | -$17.2M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -$22.7M | |
Operating Income (Adjusted) | -- | -- | -- | -- | -$17.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | $1.2M | $5.7M | |
Other Inc / (Exp) | -- | -- | -- | -$162.6K | $2.2M | |
Operating Expenses | -- | -- | -- | $1.2M | $5.7M | |
Operating Income | -- | -- | -- | -$1.2M | -$5.7M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -$1.4M | -$3.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -$1.4M | -$3.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -$1.4M | -$3.8M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -$0.03 | -$0.07 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -$0.03 | -$0.07 | |
Weighted Average Basic Share | -- | -- | -- | $46.7M | $53M | |
Weighted Average Diluted Share | -- | -- | -- | $46.7M | $53M | |
EBITDA | -- | -- | -- | -$1.4M | -$3.7M | |
EBIT | -- | -- | -- | -$1.4M | -$3.7M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -$1.2M | -$5.7M | |
Operating Income (Adjusted) | -- | -- | -- | -$1.4M | -$3.7M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | -- | $1.3M | $912.6K | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | $424.1K | $604.6K | |
Other Current Assets | -- | -- | -- | $2.4K | $1.8K | |
Total Current Assets | -- | -- | -- | $2.7M | $2.1M | |
Property Plant And Equipment | -- | -- | -- | $2K | $1.8M | |
Long-Term Investments | -- | -- | -- | $218.6K | $1.5M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | -- | -- | -- | $3M | $9M | |
Accounts Payable | -- | -- | -- | $1.3M | $10.3M | |
Accrued Expenses | -- | -- | -- | $151.3K | $1.8M | |
Current Portion Of Long-Term Debt | -- | -- | -- | $73K | $10M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | $3K | $1.5M | |
Total Current Liabilities | -- | -- | -- | $1.5M | $25M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | -- | $6.8M | $28.4M | |
Common Stock | -- | -- | -- | $4K | $4.6K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -$3.7M | -$19.4M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | -- | -$3.7M | -$19.4M | |
Total Liabilities and Equity | -- | -- | -- | $3M | $9M | |
Cash and Short Terms | -- | -- | -- | $1.3M | $912.6K | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | -- | $388.4K | $1.6M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | $281.7K | $318.5K | |
Total Current Assets | -- | -- | -- | $2.5M | $2.4M | |
Property Plant And Equipment | -- | -- | -- | $4.9K | $1.8M | |
Long-Term Investments | -- | -- | -- | $163.9K | $1.5M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | $640.9K | |
Total Assets | -- | -- | -- | $3.4M | $11.4M | |
Accounts Payable | -- | -- | -- | $2.4M | $11.9M | |
Accrued Expenses | -- | -- | -- | $583.1K | $1.6M | |
Current Portion Of Long-Term Debt | -- | -- | -- | $49.1K | $6.3M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | $3.4K | $1.5M | |
Total Current Liabilities | -- | -- | -- | $3M | $22.6M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | -- | $8.5M | $24.3M | |
Common Stock | -- | -- | -- | $90 | $5.6K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | -- | -$5.1M | -$12.8M | |
Total Liabilities and Equity | -- | -- | -- | $3.4M | $11.4M | |
Cash and Short Terms | -- | -- | -- | $388.4K | $1.6M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -$23.8M | |
Depreciation & Amoritzation | -- | -- | -- | -- | $1.8K | |
Stock-Based Compensation | -- | -- | -- | -- | $9.8M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -$9.7M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -$4.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | $6.2M | |
Long-Term Debt Repaid | -- | -- | -- | -- | -$1.9M | |
Repurchase of Common Stock | -- | -- | -- | -- | -$7.7K | |
Other Financing Activities | -- | -- | -- | -- | $8.1M | |
Cash From Financing | -- | -- | -- | -- | $14.2M | |
Beginning Cash (CF) | -- | -- | -- | -- | $1.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -$359.3K | |
Ending Cash (CF) | -- | -- | -- | -- | $912.6K | |
Levered Free Cash Flow | -- | -- | -- | -- | -$12.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -$1.4M | -$3.8M | |
Depreciation & Amoritzation | -- | -- | -- | $190 | $760 | |
Stock-Based Compensation | -- | -- | -- | $59.6K | $3M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -$934.7K | -$2.9M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -$3.1K | -$960.3K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -$23.8K | -$3.7M | |
Repurchase of Common Stock | -- | -- | -- | -$6K | -- | |
Other Financing Activities | -- | -- | -- | $84.2K | -$548.9K | |
Cash From Financing | -- | -- | -- | $54.4K | $4.5M | |
Beginning Cash (CF) | -- | -- | -- | $1.3M | $912.6K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -$883.4K | $675.6K | |
Ending Cash (CF) | -- | -- | -- | $388.4K | $1.6M | |
Levered Free Cash Flow | -- | -- | -- | -$937.8K | -$3.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -$26.2M | |
Depreciation & Amoritzation | -- | -- | -- | -- | $2.4K | |
Stock-Based Compensation | -- | -- | -- | $59.6K | $12.6M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -$11.7M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -$5.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -$5.5M | |
Repurchase of Common Stock | -- | -- | -- | -- | -$1.7K | |
Other Financing Activities | -- | -- | -- | -- | $7.4M | |
Cash From Financing | -- | -- | -- | -- | $18.6M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | $1.2M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -$15.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -$1.4M | -$3.8M | |
Depreciation & Amoritzation | -- | -- | -- | $190 | $760 | |
Stock-Based Compensation | -- | -- | -- | $59.6K | $3M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -$934.7K | -$2.9M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -$3.1K | -$960.3K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -$23.8K | -$3.7M | |
Repurchase of Common Stock | -- | -- | -- | -$6K | -- | |
Other Financing Activities | -- | -- | -- | $84.2K | -$548.9K | |
Cash From Financing | -- | -- | -- | $54.4K | $4.5M | |
Beginning Cash (CF) | -- | -- | -- | $1.3M | $912.6K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -$883.4K | $675.6K | |
Ending Cash (CF) | -- | -- | -- | $388.4K | $1.6M | |
Levered Free Cash Flow | -- | -- | -- | -$937.8K | -$3.8M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.